➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Colorcon
Express Scripts
Mallinckrodt
McKesson

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Toluene


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Toluene?

Toluene is an investigational drug.

There have been 9 clinical trials for Toluene. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2009.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Hepatitis, and Leukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), PTS International Inc., and University of Texas Southwestern Medical Center.

Recent Clinical Trials for Toluene
TitleSponsorPhase
Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene SulfonateFirst Affiliated Hospital of Zhejiang UniversityPhase 1
A Phase II Study of PTS100 in Primary HCC PatientsGongwin Biopharm Co., Ltd.Phase 2
A Study of PTS for Patients With Solid TumorsPTS International Inc.Phase 1

See all Toluene clinical trials

Clinical Trial Summary for Toluene

Top disease conditions for Toluene
Top clinical trial sponsors for Toluene

See all Toluene clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Moodys
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.